rs1051375

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000719.7(CACNA1C):​c.5361G>A​(p.Thr1787Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.694 in 1,608,514 control chromosomes in the GnomAD database, including 398,256 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 28886 hom., cov: 34)
Exomes 𝑓: 0.71 ( 369370 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -3.82
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-2679713-G-A is Benign according to our data. Variant chr12-2679713-G-A is described in ClinVar as [Benign]. Clinvar id is 93413.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-2679713-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.82 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.721 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.5595G>A p.Thr1865Thr synonymous_variant Exon 44 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.5328G>A p.Thr1776Thr synonymous_variant Exon 41 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.5526G>A p.Thr1842Thr synonymous_variant Exon 43 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.5505G>A p.Thr1835Thr synonymous_variant Exon 44 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.5484G>A p.Thr1828Thr synonymous_variant Exon 42 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.5451G>A p.Thr1817Thr synonymous_variant Exon 42 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.5451G>A p.Thr1817Thr synonymous_variant Exon 42 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.5451G>A p.Thr1817Thr synonymous_variant Exon 42 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.5451G>A p.Thr1817Thr synonymous_variant Exon 42 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.5445G>A p.Thr1815Thr synonymous_variant Exon 43 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.5436G>A p.Thr1812Thr synonymous_variant Exon 43 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.5421G>A p.Thr1807Thr synonymous_variant Exon 43 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.5418G>A p.Thr1806Thr synonymous_variant Exon 42 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.5418G>A p.Thr1806Thr synonymous_variant Exon 42 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.5418G>A p.Thr1806Thr synonymous_variant Exon 42 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.5412G>A p.Thr1804Thr synonymous_variant Exon 42 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.5403G>A p.Thr1801Thr synonymous_variant Exon 42 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.5385G>A p.Thr1795Thr synonymous_variant Exon 41 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.5385G>A p.Thr1795Thr synonymous_variant Exon 41 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.5379G>A p.Thr1793Thr synonymous_variant Exon 41 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.5361G>A p.Thr1787Thr synonymous_variant Exon 42 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.5352G>A p.Thr1784Thr synonymous_variant Exon 42 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.5328G>A p.Thr1776Thr synonymous_variant Exon 41 of 46 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.578
AC:
87834
AN:
152028
Hom.:
28877
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.236
Gnomad AMI
AF:
0.613
Gnomad AMR
AF:
0.644
Gnomad ASJ
AF:
0.672
Gnomad EAS
AF:
0.624
Gnomad SAS
AF:
0.667
Gnomad FIN
AF:
0.767
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.726
Gnomad OTH
AF:
0.586
GnomAD3 exomes
AF:
0.677
AC:
160515
AN:
236924
Hom.:
55999
AF XY:
0.683
AC XY:
88041
AN XY:
128962
show subpopulations
Gnomad AFR exome
AF:
0.236
Gnomad AMR exome
AF:
0.706
Gnomad ASJ exome
AF:
0.664
Gnomad EAS exome
AF:
0.624
Gnomad SAS exome
AF:
0.665
Gnomad FIN exome
AF:
0.763
Gnomad NFE exome
AF:
0.723
Gnomad OTH exome
AF:
0.676
GnomAD4 exome
AF:
0.706
AC:
1028616
AN:
1456368
Hom.:
369370
Cov.:
61
AF XY:
0.706
AC XY:
511204
AN XY:
724000
show subpopulations
Gnomad4 AFR exome
AF:
0.211
Gnomad4 AMR exome
AF:
0.696
Gnomad4 ASJ exome
AF:
0.661
Gnomad4 EAS exome
AF:
0.598
Gnomad4 SAS exome
AF:
0.657
Gnomad4 FIN exome
AF:
0.758
Gnomad4 NFE exome
AF:
0.731
Gnomad4 OTH exome
AF:
0.671
GnomAD4 genome
AF:
0.577
AC:
87853
AN:
152146
Hom.:
28886
Cov.:
34
AF XY:
0.581
AC XY:
43218
AN XY:
74394
show subpopulations
Gnomad4 AFR
AF:
0.236
Gnomad4 AMR
AF:
0.644
Gnomad4 ASJ
AF:
0.672
Gnomad4 EAS
AF:
0.623
Gnomad4 SAS
AF:
0.666
Gnomad4 FIN
AF:
0.767
Gnomad4 NFE
AF:
0.727
Gnomad4 OTH
AF:
0.589
Alfa
AF:
0.681
Hom.:
18547
Bravo
AF:
0.553
Asia WGS
AF:
0.637
AC:
2211
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 10, 2011
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 13, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Timothy syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Long QT syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Sep 04, 2015
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.0040
DANN
Benign
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1051375; hg19: chr12-2788879; COSMIC: COSV59695567; COSMIC: COSV59695567; API